Patient Commitment Preferences for Medication AdherenceNCT01305590
Understanding Medication Adherence Among HIV Patients
A study testing Survey to Understand Medication Adherence among HIV Patients in people with Patient Commitment Preferences for Medication Adherence, run by National Bureau of Economic Research, Inc. at 1 site in United States.
Trial summary
In anticipation of a pilot study incorporating behavioral economics into the treatment of infectious diseases, we will conduct a survey with HIV/AIDS patients at the Ponce Clinic (Infectious Disease Program of Grady Memorial Hospital, Emory University School of Medicine, Atlanta, GA). Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Patient Commitment Preferences for Medication Adherence
- What is being tested?
- Survey to Understand Medication Adherence among HIV Patients
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 200 participants
- Where
- 1 siteUnited States
- Study dates
- Jul 2011to Jul 2011
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- HIV/AIDS patients currently receiving treatment at the Ponce Clinic at the Infectious Disease Program of Grady Memorial Hospital (Emory University School of Medicine).
Who cannot join
None listed.
Trial locations and contacts
1 site in 1 country.
United States1 site
Ponce Clinic, Emory University School of Medicine
Atlanta, Georgia, 30308
About this study
In anticipation of a pilot study incorporating behavioral economics into the treatment of infectious diseases, we will conduct a survey with HIV/AIDS patients at the Ponce Clinic (Infectious Disease Program of Grady Memorial Hospital, Emory University School of Medicine, Atlanta, GA).
Read the detailed description
We are planning a study to improve health outcomes among patients with HIV/AIDS using insights from behavioral economics and financial incentives. We will conduct a survey with HIV/AIDS patients at Ponce Clinic (Infectious Disease Program of Grady Memorial Hospital, Emory University School of Medicine, Atlanta, GA). The patients will be low-income persons living with HIV/AIDS and possessing varying degrees of medication adherence. We want to better understand how this particular population would react to commitment devices designed to increase medication adherence. We will survey participants to see if they would prefer more commitment, in the form of a "Take-Medication-Get-Paid" plan; less commitment, in the form of an "Attend-Clinic-Get-Paid" plan; or if they would prefer to designate their own levels of commitment.
- Being tested
- Survey to Understand Medication Adherence among HIV Patients
- Keywords
- HIV, AIDS, Medication Adherence, Commitment Devices, Behavioral Economics
- Medical subject headings
- Acquired Immunodeficiency Syndrome, Medication Adherence
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Survey to Understand Medication Adherence among HIV PatientsOther
We want to better understand how this particular population would react to commitment devices designed to increase medication adherence. We will survey participants to see if they would prefer more commitment, in the form of a "Take-Medication-Get-Paid" plan; less commitment, in the form of an "Attend-Clinic-Get-Paid" plan; or if they would prefer to designate their own levels of commitment.
| Study group | Role | What they receive |
|---|---|---|
| Survey | Other | We will survey participants to see if they would prefer more commitment, in the form of a "Take-Medication-Get-Paid" plan; less commitment, in the form of an "Attend-Clinic-Get-Paid" plan; or if they would prefer to designate their own levels of commitment. Receives: Other: Survey to Understand Medication Adherence among HIV Patients |
What is being measured
The primary outcome is the main question the study is designed to answer.
Commitment Preferences for Increasing Medication Adherence
We will measure whether participants prefer more commitment, in the form of a "Take-Medication-Get-Paid" plan; less commitment, in the form of an "Attend-Clinic-Get-Paid" plan; or if they would prefer to designate their own levels of commitment.
Measured: Up to 4 months
Secondary outcomes (1)
Medication Adherence and Commitment Preference
We will measure how subjects' medication adherence affects their stated commitment preferences.
Measured: Up to 4 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Feb 2011 (estimated)
- Study startJul 2011
- Primary completionJul 2011
- Study completionJul 2011
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Patient Commitment Preferences for Medication AdherenceStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- We will survey participants to see if they would prefer more commitment, in the form of a "Take-Medication-Get-Paid" plan; less commitment, in the form of an "Attend-Clinic-Get-Paid" plan; or if they would prefer to designate their own levels of commitment. The study also included 70 individuals in a passive control (PC) arm, who did not receive financial incentives. Individuals in the PC arm were not enrolled in the randomized trial but met basic study eligibility criteria during the same time period.
- Masking
- None (open label)
- Enrolment
- 200 participants (actual)
Sponsor and investigators
- Lead sponsor
- National Bureau of Economic Research, Inc.
- Sponsor type
- University, hospital or other
- Collaborators
- National Institute on Aging (NIA)
- Responsible party
- Sponsor
- Investigators
- David I Laibson, Ph.D, Principal investigator, National Bureau of Economic Research
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01305590
- Sponsor's protocol ID
- 0004
- Other IDs
- P01AG005842
- Status last verified
- Mar 2018
- First submitted
- 30 Nov 2010
- Last updated
- 3 Apr 2018
- Results posted
- No
- Data monitoring committee
- No
Publications
Alsan M, Beshears J, Armstrong WS, Choi JJ, Madrian BC, Nguyen MLT, Del Rio C, Laibson D, Marconi VC. A commitment contract to achieve virologic suppression in poorly adherent patients with HIV/AIDS. AIDS. 2017 Jul 31;31(12):1765-1769. doi: 10.1097/QAD.0000000000001543.
PubMed 28514277
Study at a glance
From the registry record, last updated by the sponsor on 3 Apr 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Understanding Medication Adherence Among HIV Patients
- ClinicalTrials.gov ID
- NCT01305590
- Acronym / sponsor ID
- 0004
- Keywords
- HIV, AIDS, Medication Adherence, Commitment Devices, Behavioral Economics
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 200 participants (actual)
- Lead sponsor
- National Bureau of Economic Research, Inc.University, hospital or other
- Collaborators
- National Institute on Aging (NIA)
- Study start
- Jul 2011
- Primary completion
- Jul 2011 (actual)
- Study completion
- Jul 2011 (actual)
- First posted
- 28 Feb 2011 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In anticipation of a pilot study incorporating behavioral economics into the treatment of infectious diseases, we will conduct a survey with HIV/AIDS patients at the Ponce Clinic (Infectious Disease Program of Grady Memorial Hospital, Emory University School of Medicine, Atlanta, GA).
Detailed description
We are planning a study to improve health outcomes among patients with HIV/AIDS using insights from behavioral economics and financial incentives. We will conduct a survey with HIV/AIDS patients at Ponce Clinic (Infectious Disease Program of Grady Memorial Hospital, Emory University School of Medicine, Atlanta, GA). The patients will be low-income persons living with HIV/AIDS and possessing varying degrees of medication adherence. We want to better understand how this particular population would react to commitment devices designed to increase medication adherence. We will survey participants to see if they would prefer more commitment, in the form of a "Take-Medication-Get-Paid" plan; less commitment, in the form of an "Attend-Clinic-Get-Paid" plan; or if they would prefer to designate their own levels of commitment.
Study design
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- We will survey participants to see if they would prefer more commitment, in the form of a "Take-Medication-Get-Paid" plan; less commitment, in the form of an "Attend-Clinic-Get-Paid" plan; or if they would prefer to designate their own levels of commitment. The study also included 70 individuals in a passive control (PC) arm, who did not receive financial incentives. Individuals in the PC arm were not enrolled in the randomized trial but met basic study eligibility criteria during the same time period.
| Arm | Type | Receives |
|---|---|---|
| Survey | Other | Other: Survey to Understand Medication Adherence among HIV PatientsWe will survey participants to see if they would prefer more commitment, in the form of a "Take-Medication-Get-Paid" plan; less commitment, in the form of an "Attend-Clinic-Get-Paid" plan; or if they would prefer to designate their own levels of commitment. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- HIV/AIDS patients currently receiving treatment at the Ponce Clinic at the Infectious Disease Program of Grady Memorial Hospital (Emory University School of Medicine).
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Survey to Understand Medication Adherence among HIV PatientsWe want to better understand how this particular population would react to commitment devices designed to increase medication adherence. We will survey participants to see if they would prefer more commitment, in the form of a "Take-Medication-Get-Paid" plan; less commitment, in the form of an "Attend-Clinic-Get-Paid" plan; or if they would prefer to designate their own levels of commitment. | Other | Survey |
Primary outcome
Commitment Preferences for Increasing Medication Adherence
Time frame: Up to 4 months
We will measure whether participants prefer more commitment, in the form of a "Take-Medication-Get-Paid" plan; less commitment, in the form of an "Attend-Clinic-Get-Paid" plan; or if they would prefer to designate their own levels of commitment.
1 secondary outcome
Medication Adherence and Commitment Preference
Time frame: Up to 4 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Apr 2018.
- Results publication: PubMed 28514277Alsan M, Beshears J, Armstrong WS, Choi JJ, Madrian BC, Nguyen MLT, Del Rio C, Laibson D, Marconi VC. A commitment contract to achieve virologic suppression in poorly adherent patients with HIV/AIDS. AIDS. 2017 Jul 31;31(12):1765-1769. doi: 10.1097/QAD.0000000000001543.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
David I Laibson, Ph.D principal investigator
National Bureau of Economic Research
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Survey to Understand Medication Adherence among HIV Patients in people with Patient Commitment Preferences for Medication Adherence, run by National Bureau of Economic Research, Inc. at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 3 Apr 2018. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Commitment Preferences for Increasing Medication Adherence (time frame: Up to 4 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01305590, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Apr 2018.